The initial public offering (IPO) of pharmaceutical company Rubicon Research is now open for subscription. The 3-day subscription window for Rs 1,377.50 crore will end on October 13, 2025. According ...
We wrote last week about the record year for special purpose acquisition companies (SPACs) in 2021. We counted over 1,000 new listings last year, and remarkably over 59% were SPACs. Today we explore ...
Rubicon Research is set to launch its initial public offering (IPO) for subscription from Thursday, 9 October and close on Monday, 13 October, setting the price band at Rs 461–485 per share. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback